Zeitschriftenartikel zum Thema „RSA advisors/referents“
Geben Sie eine Quelle nach APA, MLA, Chicago, Harvard und anderen Zitierweisen an
Machen Sie sich mit Top-50 Zeitschriftenartikel für die Forschung zum Thema "RSA advisors/referents" bekannt.
Neben jedem Werk im Literaturverzeichnis ist die Option "Zur Bibliographie hinzufügen" verfügbar. Nutzen Sie sie, wird Ihre bibliographische Angabe des gewählten Werkes nach der nötigen Zitierweise (APA, MLA, Harvard, Chicago, Vancouver usw.) automatisch gestaltet.
Sie können auch den vollen Text der wissenschaftlichen Publikation im PDF-Format herunterladen und eine Online-Annotation der Arbeit lesen, wenn die relevanten Parameter in den Metadaten verfügbar sind.
Sehen Sie die Zeitschriftenartikel für verschiedene Spezialgebieten durch und erstellen Sie Ihre Bibliographie auf korrekte Weise.
Carande, Robert. „Reference Advisory Systems (RAS): Some Practical Issues“. Reference Services Review 17, Nr. 3 (März 1989): 87–90. http://dx.doi.org/10.1108/eb049069.
Der volle Inhalt der QuelleAmbrogi, Federica. „Elisa Paini (1863-1924). Wife and «unbeatable collaborator» of Luigi Credaro“. Rivista di Storia dell’Educazione 7, Nr. 2 (04.12.2020): 133–44. http://dx.doi.org/10.36253/rse-9865.
Der volle Inhalt der QuelleWalker, Christopher J., Junke Wang, Alyssa I. Clay-Gilmour, Krzysztof Mrózek, Deedra Nicolet, Christopher C. Oakes, Jessica Kohlschmidt et al. „Meta-Analysis of Genome-Wide Association Studies of Acute Myeloid Leukemia (AML) Patients Identifies Variants Associated with Risk of 11q23/KMT2A-Translocated and Core-Binding Factor (CBF) AML and Suggests a Role for Transcription Elongation in Leukemogenesis“. Blood 136, Supplement 1 (05.11.2020): 29–30. http://dx.doi.org/10.1182/blood-2020-141653.
Der volle Inhalt der QuelleVisconte, Valeria, Bartlomiej P. Przychodzen, Vera Adema, Cassandra M. Hirsch, Allison Noe, Rachel Toth, Christina Snider et al. „Development of a Novel Class of Agents Targeting the RNA-Splicing Machinery in Myeloid Malignancies“. Blood 132, Supplement 1 (29.11.2018): 211. http://dx.doi.org/10.1182/blood-2018-99-116411.
Der volle Inhalt der QuelleYalniz, Fevzi F., Rima M. Saliba, Orhan K. Yucel, Guillermo Garcia-Manero, Jeremy Ramdial, Uday Popat, Stefan O. Ciurea et al. „Somatic Mutations Improve Risk Classification By Cytogenetic Abnormalities in Patients with Myelodysplastic Syndrome after Hematopoietic Stem Cell Transplantation“. Blood 134, Supplement_1 (13.11.2019): 512. http://dx.doi.org/10.1182/blood-2019-125937.
Der volle Inhalt der QuelleMurphy, Tracy, Stanley W. K. Ng, Tong Zhang, Ian King, Andrea Arruda, Jaime O. Claudio, Narmin Ibrahimova et al. „Trial in Progress: Feasibility and Validation Study of the LSC17 Score in Acute Myeloid Leukemia Patients“. Blood 134, Supplement_1 (13.11.2019): 2682. http://dx.doi.org/10.1182/blood-2019-130532.
Der volle Inhalt der QuelleMahevas, Matthieu, Stephanie Guillet, Jean-Francois Viallard, Delphine Gobert, Marion Malphettes, Stephane Cheze, Francois Lefrere et al. „Rate of Prolonged Response after Stopping Thrombopoietin-Receptor Agonists Treatment in Primary Immune Thrombocytopenia (ITP): Results from a Nationwide Prospective Multicenter Interventional Study (STOPAGO)“. Blood 138, Supplement 1 (05.11.2021): 583. http://dx.doi.org/10.1182/blood-2021-152767.
Der volle Inhalt der QuelleTomaz, Victória, Karina Griesi-Oliveira, Renato D. Puga, Fabio Pires de Souza Santos, Nelson Hamerschlak und Paulo Vidal Campregher. „Identification of Gene Networks Associated with the Anti-Leukemic Effect of Anti-Inflammatory Drugs on Acute Myeloid Leukemia Cell Lines“. Blood 138, Supplement 1 (05.11.2021): 4343. http://dx.doi.org/10.1182/blood-2021-153903.
Der volle Inhalt der QuellePerumal, Deepak, Alessandro Lagana', Alex Rubinsteyn, John P. Finnigan, Pei-Yu Kuo, Violetta V. Leshchenko, Ajai Chari et al. „Patient-Specific Mutation-Derived Tumor Antigens As Targets for Cancer Immunotherapy in Multiple Myeloma“. Blood 126, Nr. 23 (03.12.2015): 1851. http://dx.doi.org/10.1182/blood.v126.23.1851.1851.
Der volle Inhalt der QuelleYao, Lijun, Reyka G. Jayasinghe, Beena E. Thomas, Swati S. Bhasin, Nicolas Fernandez, Taxiarchis Kourelis, Deon Doxie et al. „Integrated Cytof, Scrna-Seq and Cite-Seq Analysis of Bone Marrow Immune Microenvironment in the Mmrf Commpass Study“. Blood 136, Supplement 1 (05.11.2020): 28–29. http://dx.doi.org/10.1182/blood-2020-142534.
Der volle Inhalt der QuellePelham, Robert J., Xuguang Hu, Philippe Moreau, Albert Oriol, Hang Quach, Tibor Kovacsovics, Jonathan J. Keats, Shibao Feng, Amy S. Kimball und Meletios A. Dimopoulos. „Genomic Predictors of Progression-Free Survival Among Patients with Relapsed or Refractory Multiple Myeloma Treated with Carfilzomib and Dexamethasone or Bortezomib and Dexamethasone in the Phase 3 Endeavor Trial“. Blood 130, Suppl_1 (07.12.2017): 839. http://dx.doi.org/10.1182/blood.v130.suppl_1.839.839.
Der volle Inhalt der QuelleMageau, Arthur, Louis Terriou, Mikael Ebbo, Odile Souchaud-Debouverie, Corentin Orvain, Julie Graveleau, Jean-Christophe Lega et al. „Splenectomy for Primary Immune Thrombocytopenia Revisited at the Era of Thrombopoietin Receptor Agonists: New Insights for an Old Treatment“. Blood 138, Supplement 1 (05.11.2021): 17. http://dx.doi.org/10.1182/blood-2021-147450.
Der volle Inhalt der QuelleBrummaier, Tobias, Basirudeen Syed Ahamed Kabeer, Stephen Lindow, Justin C. Konje, Sasithon Pukrittayaamee, Juerg Utzinger, Mohammed Toufiq et al. „A prospective cohort for the investigation of alteration in temporal transcriptional and microbiome trajectories preceding preterm birth: a study protocol“. BMJ Open 9, Nr. 1 (Januar 2019): e023417. http://dx.doi.org/10.1136/bmjopen-2018-023417.
Der volle Inhalt der QuelleCroucher, Danielle C., Marta Chesi, Zhihua Li, Victoria Marie Garbitt, Meaghen E. Sharik, Daniel Waller, Michael Sebag, P. Leif Bergsagel, Trevor J. Pugh und Suzanne Trudel. „A Single-Cell Transcriptional Analysis of Tumour Cells and the Immune Microenvironment during Disease Evolution in a Transgenic Mouse Model of Myeloma“. Blood 132, Supplement 1 (29.11.2018): 56. http://dx.doi.org/10.1182/blood-2018-99-118691.
Der volle Inhalt der QuelleNicolini, Franck E., Vincent Alcazer, Stephanie Dulucq, Sandrine Hayette, Jean-Michel Cayuela, Stephane Morisset, Christophe Bouvier, Francois-Xavier Mahon, Gabriel Etienne und Delphine Rea. „The Outcome of Treatment-Free Remission after First-Line Nilotinib or Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients Is Different“. Blood 138, Supplement 1 (05.11.2021): 2552. http://dx.doi.org/10.1182/blood-2021-146722.
Der volle Inhalt der QuelleRoeser, Anais, Guillaume Moulis, Mikael Ebbo, Louis Terriou, Elsa Poullot, Bertrand Lioger, Marie Chilles et al. „A Retrospective Multicenter Case Study Evaluating the Characteristics, Management and Outcome of Acquired Amegakaryocytic Thrombocytopenia“. Blood 138, Supplement 1 (05.11.2021): 3167. http://dx.doi.org/10.1182/blood-2021-153388.
Der volle Inhalt der QuelleBloehdorn, Johannes, Julia Krzykalla, Billy Michael Chelliah Jebaraj, Karlheinz Holzmann, Jasmin Bahlo, Sandra Robrecht, Kathryn Humphrey et al. „MYC Pathway Activation Is Frequently Observed in Treatment-Naive CLL and Defines a Subgroup with Particular Benefit from the Addition of Rituximab to Chemotherapy“. Blood 132, Supplement 1 (29.11.2018): 1866. http://dx.doi.org/10.1182/blood-2018-99-116937.
Der volle Inhalt der QuelleFulciniti, Mariateresa, Charles Y. Lin, Mehmet K. Samur, Matthew Lawlor, Kenneth C. Anderson, James E. Bradner und Nikhil C. Munshi. „Discovery and Characterization of Promoter and Super-Enhancer-Associated Dependencies through E2F and BET Bromodomains in Multiple Myeloma“. Blood 126, Nr. 23 (03.12.2015): 838. http://dx.doi.org/10.1182/blood.v126.23.838.838.
Der volle Inhalt der Quellevan Beers, Erik H., Martin H. Van Vliet, Kenneth C. Anderson, Ajai Chari, Sundar Jagannath, Andrzej Jakubowiak, Shaji K. Kumar et al. „High Risk Multiple Myeloma Cases Are Identified In An MMRC Led Study By The SKY92 Gene Signature (MMprofiler)“. Blood 122, Nr. 21 (15.11.2013): 1854. http://dx.doi.org/10.1182/blood.v122.21.1854.1854.
Der volle Inhalt der QuelleAsmann, Yan, Ying Li, Taxiarchis Kourelis, Moritz Binder, Wilson I. Gonsalves, Henan Zhang, Anatilde Gonzalez Guerrico et al. „Single Cell Transcriptome Profile of Myeloma and Immune Cell Characteristics in Patients with Durable Response Post CART“. Blood 138, Supplement 1 (05.11.2021): 3838. http://dx.doi.org/10.1182/blood-2021-153254.
Der volle Inhalt der QuelleMurphy, Tracy, Stanley W. K. Ng, Ian King, Tong Zhang, Andrea Arruda, Narmin Ibrahimova, Jaime O. Claudio et al. „Inferior Outcomes with a High LSC17 Score Can be Improved with Flag-IDA“. Blood 136, Supplement 1 (05.11.2020): 35–36. http://dx.doi.org/10.1182/blood-2020-138943.
Der volle Inhalt der QuelleCatalano, Calogerina, Joanna Blocka, Stefanie Huhn, Nagarajan Paramasivam, Matthias Schlesner, Niels Weinhold, Rolf Sijmons et al. „Characterization of Rare Germline Variants in Familial Multiple Myeloma“. Blood 136, Supplement 1 (05.11.2020): 45–46. http://dx.doi.org/10.1182/blood-2020-142253.
Der volle Inhalt der QuelleTirier, Stephan M., Jan-Philipp Mallm, Nicola Casiraghi, Hana Susak, Nicola Giesen, Alexandra M. Poos, Katharina Bauer et al. „Dissecting Heterogeneity of Tumor Cells and Their Microenvironment in Refractory Multiple Myeloma“. Blood 134, Supplement_1 (13.11.2019): 571. http://dx.doi.org/10.1182/blood-2019-128625.
Der volle Inhalt der QuelleMaeding, Nicole, Daniela Asslaber, Nadja Zaborsky, Andreas Villunger, Richard Greil und Alexander Egle. „Lack of Bmf Facilitates the Selection of Highly Responsive B-Cell Receptor Clones in Chronic Lymphocytic Leukemia“. Blood 138, Supplement 1 (05.11.2021): 1543. http://dx.doi.org/10.1182/blood-2021-152216.
Der volle Inhalt der QuelleGarg, Tarun K., Ricky D. Edmondson, Shweta S. Chavan, Katie Stone, Justin M. Stivers, Jessica I. Warden, Veronica Macleod et al. „Differential ICAM3 Gene Expression Correlates with Susceptibility to Natural Killer Cell-Mediated Lysis in Multiple Myeloma“. Blood 126, Nr. 23 (03.12.2015): 2990. http://dx.doi.org/10.1182/blood.v126.23.2990.2990.
Der volle Inhalt der QuelleMehr, Shaadi, Daniel Auclair, Mark Hamilton, Leon Rozenblit, Hearn Jay Cho, Lijun Yao, Reyka G. Jayasinghe et al. „Architecture of Sample Preparation and Data Governance of Immuno-Genomic Data Collected from Bone Marrow and Peripheral Blood Samples Obtained from Multiple Myeloma Patients“. Blood 136, Supplement 1 (05.11.2020): 17–18. http://dx.doi.org/10.1182/blood-2020-142882.
Der volle Inhalt der QuelleTarantino, Michael D., Michael Vredenburg, Wei Tian, Brian Jamieson und Kashyap B. Patel. „Efficacy Analyses from the Immune Thrombocytopenia (ITP) Clinical Development Program for Avatrombopag: Comparisons with Placebo and Eltrombopag“. Blood 136, Supplement 1 (05.11.2020): 23–24. http://dx.doi.org/10.1182/blood-2020-142788.
Der volle Inhalt der QuelleWhite, Brian S., Suleiman A. Khan, Muhammad Ammad-ud-din, Swapnil Potdar, Mike J. Mason, Cristina E. Tognon, Brian J. Druker et al. „Comparative Analysis of Independent Ex Vivo functional Drug Screens Identifies Predictive Biomarkers of BCL-2 Inhibitor Response in AML“. Blood 132, Supplement 1 (29.11.2018): 2763. http://dx.doi.org/10.1182/blood-2018-99-111916.
Der volle Inhalt der QuelleMishima, Yuji, Michele Moschetta, Jiantao Shi, Francois Mercier, Salomon Manier, Siobhan Glavey, Michaela R. Reagan et al. „Clonal-Heterogeneity and Propensity for Bone Metastasis in Multiple Myeloma“. Blood 124, Nr. 21 (06.12.2014): 3370. http://dx.doi.org/10.1182/blood.v124.21.3370.3370.
Der volle Inhalt der QuelleWang, Tianjiao, Hua Sun, Daniel Cui Zhou, Ruiyang Liu, Lijun Yao, Mark A. Fiala, Daniel R. Kohnen et al. „Single-Cell Pathway Enrichment and Regulatory Profiling of Multiple Myeloma across Disease Stages“. Blood 134, Supplement_1 (13.11.2019): 364. http://dx.doi.org/10.1182/blood-2019-131361.
Der volle Inhalt der QuelleSpencer, Andrew, Tiffany Khong und Maoshan Chenn. „MCL-1 Inhibitor-Induced Killing of Multiple Myeloma Is Modulated By the Relative Level of Expression of Pro-Survival Members of the BCL-2 Family and the Proto-Oncogene MYC“. Blood 134, Supplement_1 (13.11.2019): 1825. http://dx.doi.org/10.1182/blood-2019-127843.
Der volle Inhalt der QuelleMatino, Davide, Giancarlo Castaman, Giovanni Di Minno, Paola Giordano, Maria Elisa Mancuso, Emanuela Marchesini, Flora Peyvandi et al. „Prospective Study of the Immunological Mechanisms of Immune Tolerance Induction in Severe Haemophilia a Patients with Inhibitors: Preliminary Analysis of a Multi-Center Longitudinal Study“. Blood 132, Supplement 1 (29.11.2018): 3781. http://dx.doi.org/10.1182/blood-2018-99-119568.
Der volle Inhalt der QuelleWallace, Sarah, Victoria Hall, Andre Charlett, Peter D. Kirwan, Michele Cole, Natalie Gillson, Ana Atti et al. „Impact of prior SARS-CoV-2 infection and COVID-19 vaccination on the subsequent incidence of COVID-19: a multicentre prospective cohort study among UK healthcare workers – the SIREN (Sarscov2 Immunity & REinfection EvaluatioN) study protocol“. BMJ Open 12, Nr. 6 (Juni 2022): e054336. http://dx.doi.org/10.1136/bmjopen-2021-054336.
Der volle Inhalt der QuelleLee, Shawn, Federico Antillón, Deqing Pei, Wenjian Yang, Kathryn G. Roberts, Zhenhua Li, Meenakshi Devidas et al. „The Impact of Genetic Ancestry on the Biology and Prognosis of Childhood Acute Lymphoblastic Leukemia“. Blood 138, Supplement 1 (05.11.2021): 3476. http://dx.doi.org/10.1182/blood-2021-145655.
Der volle Inhalt der QuelleSauer, Sandra, Christos Sachpekidis, Simone Brandelik, Daniel Spira, Stefanie Huhn, Barbara Wagner, Manuela Hummel et al. „Prospective Evaluation of 18-F FDG PET/CT and Biopsies of Osteolytic Lesions and Random Bone Marrow Samples in Newly Diagnosed Multiple Myeloma Patients“. Blood 132, Supplement 1 (29.11.2018): 3180. http://dx.doi.org/10.1182/blood-2018-99-115201.
Der volle Inhalt der QuelleRoter, Kyle, Donglei Hu, Alyssa Clay-Gilmour, Scott Huntsman, Nina D. Shah, Sandy W. Wong, Thomas G. Martin et al. „Germline Variation Predicts Treatment Response in Multiple Myeloma“. Blood 134, Supplement_1 (13.11.2019): 4397. http://dx.doi.org/10.1182/blood-2019-129344.
Der volle Inhalt der QuellePoos, Alexandra M., Jan-Philipp Mallm, Stephan M. Tirier, Nicola Casiraghi, Hana Susak, Nicola Giesen, Katharina Bauer et al. „A Comprehensive Analysis of Single-Cell Chromatin Accessibility and Gene Expression Identifies Intra-Tumor Heterogeneity and Molecular Treatment Responses in Relapsed/Refractory Multiple Myeloma“. Blood 134, Supplement_1 (13.11.2019): 575. http://dx.doi.org/10.1182/blood-2019-130051.
Der volle Inhalt der QuelleCoffey, David G., Francesco Maura, Edgar Gonzalez-Kozlova, Javier Diaz-Mejia3, Ping Luo, Yong Zhang, Yuexin Xu et al. „Normalization of the Immune Microenvironment during Lenalidomide Maintenance Is Associated with Sustained MRD Negativity in Patients with Multiple Myeloma“. Blood 138, Supplement 1 (05.11.2021): 329. http://dx.doi.org/10.1182/blood-2021-154506.
Der volle Inhalt der QuelleSheih, Alyssa, Jonathan L. Golob, Abir Bhattacharyya, Michael C. Wu, Aesha Vakil, Sujatha Srinivasan, Steven A. Pergam, David N. Fredricks und Cameron J. Turtle. „Impact of Intestinal Microbiota on Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Stem Cell Transplantation“. Blood 132, Supplement 1 (29.11.2018): 3393. http://dx.doi.org/10.1182/blood-2018-99-115158.
Der volle Inhalt der QuelleMcCarthy, John J. „Alan S. Kaye (ed.) (1997). Phonologies of Asia and Africa (including the Caucasus). Technical advisor: Peter T. Daniels. Winona Lake, Indiana: Eisenbrauns. 2 vols. Pp. xxi+1041.“ Phonology 15, Nr. 1 (August 1998): 111–14. http://dx.doi.org/10.1017/s0952675798003509.
Der volle Inhalt der QuelleArkian, Muhammad Reyzha Noorsyam, M. Subur Drajat und Dadi Ahmadi. „Peran Public Relations dalam Film Hancock“. Inter Komunika : Jurnal Komunikasi 3, Nr. 2 (11.12.2018): 145. http://dx.doi.org/10.33376/ik.v3i2.214.
Der volle Inhalt der QuelleDecroocq, Justine, Rudy Birsen, Jordi Mano, Guillemette Fouquet, Mathilde Gotanègre, Laury Poulain, Sarah Mouche et al. „Combination of the MEK Inhibitor Trametinib and Pyrvinium Pamoate Efficiently Targets RAS Pathway-Mutated Acute Myeloid Leukemia in Preclinical Models“. Blood 134, Supplement_1 (13.11.2019): 2671. http://dx.doi.org/10.1182/blood-2019-123418.
Der volle Inhalt der QuelleZhang, Haiyu, Bing Zhang, Xiangqian Guo, Naznin Haq, Robert B. West, James B. Bussel und James L. Zehnder. „Effects of Thrombopoietin Mimetics on Patients with Chronic ITP: Perspectives from Blood Transcriptome Profiling Analysis“. Blood 124, Nr. 21 (06.12.2014): 2780. http://dx.doi.org/10.1182/blood.v124.21.2780.2780.
Der volle Inhalt der QuelleBai, Xiaoying, Jennifer Trowbridge, Joseph Lee, Stuart H. Orkin und Leonard I. Zon. „Analysis of TIF1gamma Conditional Knockout Establishes a Requirement for the Differentiation of Multiple Hematopoietic Lineages“. Blood 116, Nr. 21 (19.11.2010): 744. http://dx.doi.org/10.1182/blood.v116.21.744.744.
Der volle Inhalt der QuelleSharma, Priyanka, Sujan Piya, Huaxian Ma, Natalia Baran, Malgorzata Anna Zal, Christopher J. Hindley, Kim-Hien Dao et al. „ERK1/2 Inhibition Overcomes Resistance in Acute Myeloid Leukemia (AML) and Alters Mitochondrial Dynamics“. Blood 138, Supplement 1 (05.11.2021): 3338. http://dx.doi.org/10.1182/blood-2021-151579.
Der volle Inhalt der QuelleStahlberg, Eric, Lynn Borkon, Ruth Frost, Sara Jones, Amar Khalsa, Lauren Lewis, Emily Greenspan und Sunita Menon. „Abstract 7432: Improving FAIRness of computational approaches for cancer: The computational resources for cancer research portal“. Cancer Research 84, Nr. 6_Supplement (22.03.2024): 7432. http://dx.doi.org/10.1158/1538-7445.am2024-7432.
Der volle Inhalt der QuelleKumar, Ashwini, Muntasir Mamun Majumder, Jesus María Lopez Martí, Alun Parsons, Pirkko Mattila, Kimmo Porkka, Olli Kallioniemi und Caroline A. Heckman. „The Use of RNA Sequencing to Identify Disease-Specific Gene Expression Signatures and Critical Regulatory Networks Across Hematologic Malignancies“. Blood 124, Nr. 21 (06.12.2014): 2203. http://dx.doi.org/10.1182/blood.v124.21.2203.2203.
Der volle Inhalt der QuelleChen, Zhenghao, Gaspard Cretenet, Beatriz Valle-Argos, Francesco Forconi, Arnon P. Kater, Graham Packham und Eric Eldering. „Effects of Ibrutinib on Metabolic Alterations and Micro-Environmental Signalling in Chronic Lymphocytic Leukaemia“. Blood 136, Supplement 1 (05.11.2020): 36–37. http://dx.doi.org/10.1182/blood-2020-142839.
Der volle Inhalt der QuelleClarke, Stanley R., Adrianna Vlachos, Jens Lichtenberg, Nancy E. Seidel, Jaya Jagadeesh, NISC Comparative SequencingProgram, Adam M. Phillippy et al. „Whole Genome Sequencing of Diamond Blackfan Anemia Syndrome Patients Detects Mutations That Alter mRNA Splicing“. Blood 138, Supplement 1 (05.11.2021): 863. http://dx.doi.org/10.1182/blood-2021-145622.
Der volle Inhalt der QuelleSu, Christopher T., Liying Chen, Jason Chen, Brian Parkin, Avery Polk, Malathi Kandarpa, Craig E. Cole et al. „Role of Aneuploidy in Transcriptional Regulation and Clinical Prognosis in Relapsed and/or Refractory Multiple Myeloma (RRMM)“. Blood 136, Supplement 1 (05.11.2020): 45–46. http://dx.doi.org/10.1182/blood-2020-134558.
Der volle Inhalt der Quelle